Respondents (n = 134) | Non-respondents (n = 828) | p-value | |
---|---|---|---|
Age > 50 (n, %) | 85 (64)a | 477 (57) b | 0.20 |
Female (n, %) | 71 (53) | 359 (43) | 0.05 |
Practice state (n, %) | |||
New South Wales | 43 (32) | 288 (35) | 0.04 |
Victoria | 40 (30) | 173 (21) | |
Queensland | 20 (15) | 180 (22) | |
Western Australia | 14 (10) | 83 (10) | |
South Australia | 12 (9) | 61 (7) | |
North Territory | 3 (2) | 5 (1) | |
Australian Capital Territory | 2 (1) | 15 (2) | |
Tasmania | 0 | 23 (3) | |
CHB prevalence in practice PHN (%) (mean, SD) | 1.00 (0.03) | 0.99 (0.01) | 0.60 |
CHB prevalence of practice PHN (%) (n, %) | |||
[0.52, 0.76) | 36 (27) | 221 (27) | 0.80 |
[0.76, 1.00) | 43 (32) | 284 (34) | |
[1.00, 1.23) | 19 (14) | 137 (17) | |
[1.23,1.47) | 28 (21) | 149 (18) | |
[1.47, 1.71] | 8 (6) | 37 (4) |